Sartorius AG (SRT3)
Industry Medical Instruments & Supplies
This stock can be held in an Investment ISA and an Investment Account
Sell
€242.00
Buy
€243.90
€-5.40 (-2.18%)
Prices updated at 12 Dec 2025, 17:29 CET
| Prices minimum 15 mins delay
Prices in EUR
Sartorius AG is a pharmaceutical and laboratory equipment supplier for biopharmaceutical production and laboratory environments. Its business is subdivided into two divisions, Bioprocess Solution, and Lab Products & Services.
-0.53%
Important documents: Please ensure that you have read the Pre-sale Illustrations document & Doing Business with Fidelity document (incorporating the Fidelity Client Terms) and
- Key stats
- Price
- Fair value
- Dividends
- News
- Financials
- Valuation
- Profile
Sector
Healthcare
Industry
Medical Instruments & Supplies
Chairman
Dr. Lothar Kappich
CEO
-
Most recent earnings
31 Dec 2024
Fiscal year end
31 Dec 2024
Employees
13,878
Head office
Otto-Brenner-Strasse 20
Gottingen
Germany
37079
Key personnel
Owner name | Salary |
|---|---|
Professor Dr. David Raymond Ebsworth, PhD Member of the Supervisory Board | - |
Professor Dr. Klaus Ruediger Trutzschler Member of the Supervisory Board | - |
Dr. Lothar Kappich Chairman of the Supervisory Board | - |
Ms. Annette Becker Member of the Supervisory Board | - |
Dr. Daniela Favoccia Member of the Supervisory Board | - |
Ms. Petra Kirchhoff Member of the Supervisory Board | - |
Mr. Dietmar Muller Member of the Supervisory Board | - |
Ms. Ilke Hildegard Panzer Member of the Supervisory Board | - |
Mr. Hermann Jens Ritzau Member of the Supervisory Board | - |
Mr. Frank Riemensperger Member of the Supervisory Board | - |
Ms. Sabrina Wirth Member of the Supervisory Board | - |
Top 5 shareholders
Owner name | No. of shares |
|---|---|
| AXA Pension 2039-2041 | 59,373,023 |
| AXA Pension 2036-2038 | 41,796,479 |
| AXA Pension 2033-2035 | 27,441,468 |
| Vanguard | 1,405,231 |
| Vanguard International Growth Fund | 1,316,375 |
Director dealings
Date | Action |
|---|---|
| No data | |
Please note that past performance is not a reliable indicator of future returns.